organization · Reporting owner
Odyssey Health, Inc.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ORAGENICS INCOGEN · Entity 8495 | 10% owner | June 17, 2025 | June 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ORAGENICS INC
Report date June 17, 2025 · Filed June 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - OGENSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-06-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-06-17 · Sale · Disposed 2,000 · Balance 5,044 Row 2 · 2025-06-18 · Sale · Disposed 5,044 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2025 Filed Jun 18, 2025 21:10 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock - OGEN | 5,044 | $4.26 | $21,487.44 |
DisclosureSEC source: 0001683168-25-004612 · ownership.xml · nonDerivative · entry 2 Odyssey Health, Inc. · CIK 0001626644 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 21:10 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock - OGEN | 2,000 | $4.46 | $8,920.00 |
DisclosureSEC source: 0001683168-25-004612 · ownership.xml · nonDerivative · entry 1 Odyssey Health, Inc. · CIK 0001626644 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,044 Read SEC document |
| June 16, 2025 Filed Jun 16, 2025 22:01 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock - OGEN | 5,000 | $4.45 | $22,250.00 |
DisclosureSEC source: 0001683168-25-004526 · ownership.xml · nonDerivative · entry 2 Odyssey Health, Inc. · CIK 0001626644 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,044 Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 22:01 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock - OGEN | 5,000 | $4.27 | $21,350.00 |
DisclosureSEC source: 0001683168-25-004526 · ownership.xml · nonDerivative · entry 1 Odyssey Health, Inc. · CIK 0001626644 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,044 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.